MLKL and cancer: Lately, the importance of immunogenic cell death (ICD) for killing cancer cells has emerged, and expression of proteins that activate this kind of cell death (such as MLKL [3]) or co-administration with molecules that enhance ICD (such as vitamin C [50]) could also result in a better antitumor outcome.